Back to Results
First PageMeta Content
Immunosuppressants / Monoclonal antibodies / Biotechnology / Drugs / Biosimilar / Biologic / Low molecular weight heparin / Insulin glargine / Pharmaceutical drug / Pharmacology / Biology / Medicine


factsheet | on biosimilar medicines patients sustainability
Add to Reading List

Document Date: 2015-06-15 10:46:19


Open Document

File Size: 729,98 KB

Share Result on Facebook

City

Brussels / /

Company

The European Biosimilars Group / /

Continent

Europe / /

Country

United Kingdom / Belgium / /

Currency

EUR / /

/

IndustryTerm

cancer treatment / manufacturing sites / pharmaceutical / healthcare systems / sector / /

MedicalCondition

Crohn's / cancer treatment Insulin Lispro Diabetes / cancer / head and neck cancer neutropenia insulin aspart diabetes / Diabetes / chronic kidney failure Follow-up / /

Organization

European Union / MEDICINES ASSOCIATION / /

/

Position

arthritis Colorectal cancer Lung cancer Colorectal cancer Head / /

ProgrammingLanguage

EC / /

Technology

transplantation / /

URL

www.egagenerics.com / /

SocialTag